CLASS II Drug recall · Reported 10 Jul 2024 · FDA Enforcement Report
Allopurinol Tablets, USP 300mg recalled by Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is recalling Allopurinol Tablets, USP 300mg per, distributed in Illinois, Mississippi, Ohio. The recall was initiated on 7 Jun 2024 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0583-2024
- FDA event ID
- 94781
- Recalling firm
- Dr. Reddy's Laboratories, Princeton, NJ
- Brand
- Allopurinol
- Manufacturer
- Dr. Reddy's Laboratories Limited
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 7 Jun 2024
- FDA classified
- 3 Jul 2024
- Reported
- 10 Jul 2024
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
Timeline
| 7 Jun 2024 | Recall initiated by company | |
| 3 Jul 2024 | Classified by FDA | +26 days |
| 10 Jul 2024 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of foreign substance.
Product as listed by the FDA
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
Where it was distributed
IL, MS, OH
Questions about this recall
Why was it recalled?
Presence of foreign substance.
Which lots are affected?
L2300594
Where was it sold?
IL, MS, OH
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Dr. Reddy's Laboratories
All 165| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Varenicline Tablets, 1mg recalled by Dr. Reddy's LaboratoriesVarenicline Tartrate | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Succinylcholine Chloride Injection, USP, 200 mg/ (20 mg/mL) recalledSuccinylcholine | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Omeprazole Delayed-release Capsules, USP, 20mg recalledOmeprazole | Dr. Reddy's Laboratories | Other | Nationwide |
| Drug | CLASS I | Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg recalledLevetiracetam | Dr. Reddy's Laboratories | Labeling Errors | Nationwide |
| Drug | CLASS III | Javygtor (sapropterin dihydrochloride) Tablets 100mg recalledJavygtor | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
Other Allopurinol recalls
All 7| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Allopurinol Tablets recalled by Cardinal HealthcareAllopurinol | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Allopurinol Tablets 100mg recalled by Preferred Pharmaceuticals | Preferred Pharmaceuticals | Foreign Material | IN |
| Drug | CLASS II | Allopurinol Tablets USP, 100 mg recalled by Accord HealthcareAllopurinol | Accord Healthcare | Foreign Material | Nationwide |
| Drug | CLASS II | Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial recalledAloprim | Mylan Institutional | Potency & Assay | Nationwide |
| Drug | CLASS III | Allopurinol Tablets, USP, 300 mg recalled by Qualitest PharmaceuticalsAllopurinol | Qualitest Pharmaceuticals | Other | Nationwide |